Klinger H, Hughes D C, O'Brien P Q. "一种坦索罗辛杂质57的合成方法" [P]. US Patent, US 11797102 B2, 2016-12-10.
发明人孙丽萍,冯建国,黄志刚. "Method for the Synthesis of Tamsulosin impurity 57" [P]. 中国发明专利, 专利号 CN 108347109 B, 授权公告日 2018-02-27.
发明人唐晓军,徐明华,郑宇鹏. "A Process for Preparing High-Purity Tamsulosin impurity 57" [P]. 中国发明专利, 专利号 CN 108668090 B, 授权公告日 2018-08-03.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 坦索罗辛杂质57 in Pharmaceutical Formulations". Anal. Chim. Acta, 2011, 952, (1), 887-902.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 坦索罗辛杂质57 as an Impurity". Food Chem., 2020, 232, (9), 3782-3799.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Tamsulosin impurity 57 Using HRMS and NMR". Chemosphere, 2017, 667, (6), 3562-3592.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 坦索罗辛杂质57 Profile in Drug Substances According to ICH Guidelines". Talanta, 2013, 460, (8), 2569-2595.